Sunday, July 09, 2023 10:15:36 PM
On May 17, the AANS, the CNS, the AANS/CNS Joint Section on Pain and the AANS/CNS Joint Section on Disorders of the Spine and Peripheral Nerves endorsed H.R. 3259, the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act. Sponsored by Reps. Terri Sewell (D-Ala.), David McKinley (R-W.V.), Ann Kuster (D-N.H.) and Brian Fitzpatrick (R-Pa.), the NOPAIN Act would require Medicare to provide adequate facility reimbursement for innovative and effective alternatives to opioids. In the letter, the neurosurgical groups pointed out that neurosurgeons are on the cutting edge of innovative, non-opioid treatments for chronic pain and acute postoperative pain. In March, the neurosurgical groups endorsed the Senate version of this legislation.
Do your own due diligence when investing. My posts are my opinion!!
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM